Literature DB >> 18204990

MicroCT liver contrast agent enhancement over time, dose, and mouse strain.

Chris E Suckow1, David B Stout.   

Abstract

PURPOSE: The aim of this study was to examine strain differences in the uptake of Fenestra liver contrast agent (LC) in Nude, C57, and severe-combined immunodeficient (SCID) mice. In addition, we aimed to determine optimum dosing and to determine if there are positron emission tomography (PET)-attenuation effects on 2-deoxy-2[F-18]fluoro-D-glucose (FDG) values due to Fenestra LC. PROCEDURES: Nude, C57, and SCID mice were injected via tail vein at 5.0, 7.5, 10.0, and 15.0 ml/kg with contrast agent and imaged using micro computed tomography (microCT) 2 h after uptake and then daily up to 7 days. Mice were imaged by microPET/CT with FDG, with or without contrast agent.
RESULTS: Significant variations in contrast were observed between mouse strains. SCID mice had significantly more spleen uptake of contrast than the other strains, and C57 mice had significantly more liver uptake of contrast than other strains. Across all strains, the spleen showed significantly higher uptake and duration of contrast than liver. Only the heart showed a significant attenuation of FDG uptake following contrast administration.
CONCLUSIONS: Strain-specific variations in Fenestra LC uptake and signal duration were observed. At 7.5 ml/kg, this contrast agent is effective for imaging for 1 day, whereas at 15 ml/kg, it can be used up to 1 week. Fenestra LC does not appear to attenuate FDG uptake at 15 ml/kg for most tissues; therefore, it can be used in conjunction with microPET imaging studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204990     DOI: 10.1007/s11307-007-0128-x

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  10 in total

1.  Polyiodinated triglyceride lipid emulsions for use as hepatoselective contrast agents in CT: effects of physicochemical properties on biodistribution and imaging profiles.

Authors:  D A Bakan; J P Weichert; M A Longino; R E Counsell
Journal:  Invest Radiol       Date:  2000-03       Impact factor: 6.016

2.  Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].

Authors:  T T Nguyen; K E Kruckeberg; J F O'Brien; Z S Ji; P S Karnes; T B Crotty; I D Hay; R W Mahley; T O'Brien
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

3.  Computed tomography contrast enhancement principles and the use of high-concentration contrast media.

Authors:  Sean Herman
Journal:  J Comput Assist Tomogr       Date:  2004 Jul-Aug       Impact factor: 1.826

4.  Small animal imaging center design: the facility at the UCLA Crump Institute for Molecular Imaging.

Authors:  David B Stout; Arion F Chatziioannou; Timothy P Lawson; Robert W Silverman; Sanjiv S Gambhir; Michael E Phelps
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

5.  Attenuation correction for small animal PET tomographs.

Authors:  Patrick L Chow; Fernando R Rannou; Arion F Chatziioannou
Journal:  Phys Med Biol       Date:  2005-04-06       Impact factor: 3.609

6.  Time-course characterization of the computed tomography contrast enhancement of an iodinated blood-pool contrast agent in mice using a volumetric flat-panel equipped computed tomography scanner.

Authors:  Nancy L Ford; Kevin C Graham; Alan C Groom; Ian C Macdonald; Ann F Chambers; David W Holdsworth
Journal:  Invest Radiol       Date:  2006-04       Impact factor: 6.016

7.  Physicochemical characterization of a synthetic lipid emulsion for hepatocyte-selective delivery of lipophilic compounds: application to polyiodinated triglycerides as contrast agents for computed tomography.

Authors:  D A Bakan; M A Longino; J P Weichert; R E Counsell
Journal:  J Pharm Sci       Date:  1996-09       Impact factor: 3.534

8.  Imaging efficacy of a hepatocyte-selective polyiodinated triglyceride for contrast-enhanced computed tomography.

Authors:  D A Bakan; J K Doerr-Stevens; J P Weichert; M A Longino; F T Lee; R E Counsell
Journal:  Am J Ther       Date:  2001 Sep-Oct       Impact factor: 2.688

9.  Chylomicron metabolism. Chylomicron uptake by bone marrow in different animal species.

Authors:  M M Hussain; R W Mahley; J K Boyles; P A Lindquist; W J Brecht; T L Innerarity
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

10.  Intravenous lipid emulsions: removal mechanisms as compared to chylomicrons.

Authors:  M Hultin; C Carneheim; K Rosenqvist; T Olivecrona
Journal:  J Lipid Res       Date:  1995-10       Impact factor: 5.922

  10 in total
  21 in total

Review 1.  Small animal imaging facility: new perspectives for the radiologist.

Authors:  R Grassi; C Cavaliere; S Cozzolino; L Mansi; S Cirillo; G Tedeschi; R Franchi; P Russo; S Cornacchia; A Rotondo
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

2.  Time-course of contrast enhancement in spleen and liver with Exia 160, Fenestra LC, and VC.

Authors:  Inneke Willekens; Tony Lahoutte; Nico Buls; Christian Vanhove; Rudi Deklerck; Axel Bossuyt; Johan de Mey
Journal:  Mol Imaging Biol       Date:  2008-12-06       Impact factor: 3.488

3.  Effect of nicotine on body composition in mice.

Authors:  Michael Mangubat; Kabirullah Lutfy; Martin L Lee; Laura Pulido; David Stout; Richard Davis; Chang-Sung Shin; Meghdi Shahbazian; Stephen Seasholtz; Amiya Sinha-Hikim; Indrani Sinha-Hikim; Laura E O'Dell; Alexei Lyzlov; Yanjun Liu; Theodore C Friedman
Journal:  J Endocrinol       Date:  2011-12-02       Impact factor: 4.286

4.  A deformable atlas of the laboratory mouse.

Authors:  Hongkai Wang; David B Stout; Arion F Chatziioannou
Journal:  Mol Imaging Biol       Date:  2015-02       Impact factor: 3.488

5.  Estimation of mouse organ locations through registration of a statistical mouse atlas with micro-CT images.

Authors:  Hongkai Wang; David B Stout; Arion F Chatziioannou
Journal:  IEEE Trans Med Imaging       Date:  2011-08-18       Impact factor: 10.048

Review 6.  Radiologic and near-infrared/optical spectroscopic imaging: where is the synergy?

Authors:  Brian W Pogue; Frederic Leblond; Venkataramanan Krishnaswamy; Keith D Paulsen
Journal:  AJR Am J Roentgenol       Date:  2010-08       Impact factor: 3.959

7.  MARS: a mouse atlas registration system based on a planar x-ray projector and an optical camera.

Authors:  Hongkai Wang; David B Stout; Richard Taschereau; Zheng Gu; Nam T Vu; David L Prout; Arion F Chatziioannou
Journal:  Phys Med Biol       Date:  2012-09-12       Impact factor: 3.609

Review 8.  X-ray-computed tomography contrast agents.

Authors:  Hrvoje Lusic; Mark W Grinstaff
Journal:  Chem Rev       Date:  2012-12-05       Impact factor: 60.622

Review 9.  Micro-CT of rodents: state-of-the-art and future perspectives.

Authors:  D P Clark; C T Badea
Journal:  Phys Med       Date:  2014-06-26       Impact factor: 2.685

10.  Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.

Authors:  Lucia Martiniova; Melanie S Kotys; David Thomasson; Daniel Schimel; Edwin W Lai; Marcelino Bernardo; Maria J Merino; James F Powers; Jan Ruzicka; Richard Kvetnansky; Peter L Choyke; Karel Pacak
Journal:  J Magn Reson Imaging       Date:  2009-03       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.